Toro, Jaime
Rivera, Juan Sebastián
Gaitán, Jairo
Rodríguez, Daniela
Serna-Corredor, Laura Andrea
Cortés-Muñoz, Fabián
Medina, Thomas
Yepes, Manuel
Article History
Received: 2 November 2022
Accepted: 30 October 2023
First Online: 2 November 2023
Declarations
:
: This study was approved as an “exempt study” by the Research Ethics Committee of the School of Medicine of Universidad de los Andes. All methods were carried out in accordance with relevant guidelines, Declaration of Helsinki and regulations. The information collected was secondary data already in the domain of Universidad de los Andes. The school of medicine approved the re-use of these datasets, which were originally collected for feedback and satisfaction with the overall program. Participation in the survey was entirely voluntary, and all participants gave their informed consent electronically. The School of medicine of Universidad de los Andes rigorously ensured anonymity and verified that data cannot be traced.
: Not applicable.
: J. Toro is an associate editor of NEJM Journal Watch Neurology and is an editorial board member for Multiple Sclerosis and Related Disorders. Manuel Yepes, J.S. Rivera, F. Cortés-Muñoz, D.S Rodríguez-Silva, T.F Medina, J. Gaitán, L.A Serna report no disclosures.